期刊文献+

甘草酸表面修饰阿霉素壳聚糖纳米粒的制备及特性研究 被引量:11

Preparation and characterization of adriamycin-loaded chitosan nanoparticles surface-modified with glycyrrhizin
下载PDF
导出
摘要 目的:制备具有肝细胞靶向的甘草酸表面修饰阿霉素壳聚糖纳米粒,并考察其理化特性。方法:采用离子凝胶法制备阿霉素壳聚糖纳米粒,再以高碘酸盐氧化法制备甘草酸表面修饰阿霉素壳聚糖纳米粒。激光透射电子显微镜观察纳米粒的形态,马尔文激光粒度仪测定其粒径。RP-HPLC法间接测定纳米粒中甘草酸结合率和阿霉素包封率,并初步研究体外甘草酸的结合稳定性和阿霉素释药特性。结果:电镜显示纳米粒呈类球形,平均粒径为179.5 nm,甘草酸结合率达到80%以上,在释放介质中,12 h的甘草酸结合率仍保持(65.2±3.4)%;纳米粒中阿霉素包封率达90%以上,体外释药缓慢,无明显的"突释"现象,72 h的累计释放百分率为(28±4.6)%。结论:本方法制备的甘草酸表面修饰阿霉素纳米粒工艺简单,包封率高,且甘草酸表面结合稳定,有望提高阿霉素的肝细胞靶向性。 Aim: To prepare and characterize the adriamycin-loaded chitosan nanoparticles of the surface-modified with glycyrrhizin ( GL-ADM-CS-NPs). Methods: Adriamycin-loaded ehitosan nanoparticles (ADM-CS-NPs) were prepared by ionic gelation, then oxidized by sodium periodate and conjugated to surface free amino groups of ADM-CS-NPs. Transmission electron microscopy was used to assess the shape of the nanoparticles. Malvern Zeta Nano-ZS was applied to measure the particle size distribution. RP-HPLC was developed to determine GL-binding ratio and adriamycin (ADM) entrapment efficiency. In addition, GL-binding stability and ADM release characteristics were investigated. Results:The GL-ADM-CS-NPs were found spherical with an average diameter of 179.5 nm. The GL-binding ratio was at least 80% and was retained to be (65.2±3.4) % after 12 h-exposure to the release medium. The ADM entrapment efficiency was at least 90%. 72-h in vitro cumulative release of ADM from GL-ADM-CS-NPs was accounted by (28 ± 4.6) %. Turthermore, there was no apparant drug "burst release" in the process. Conclusion: GL-ADM-CS-NPs prepared with the simple method developed in this paper has the properties of high drug entrapment efficiency and high GL-binding stability, which might have the potential improving the hepatocellular targeting of ADM.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2007年第6期507-511,共5页 Journal of China Pharmaceutical University
基金 广东省自然科学基金资助项目(No.040100147)
关键词 阿霉素 壳聚糖纳米粒 甘草酸 表面修饰 adriamycin chitosan nanoparticles glycyrrhizin surface-modification
  • 相关文献

参考文献11

  • 1Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro-and nanoparticles in drug delivery [J]. J Control Release, 2004, 100( 1 ) :5 - 28.
  • 2Aktas Y,Andrieux K, Alonso MJ, et al. Preparation and in ritro evaluation of chitosan nanoparticles containing a caspase inhibitor [J].Int J Pharm, 2005, 298(2) :378 - 383.
  • 3张灿,丁娅,平其能.水溶性6-O-琥珀酰-N-半乳糖化壳聚糖衍生物的制备与表征[J].中国药科大学学报,2005,36(4):291-295. 被引量:21
  • 4Park IK. Jiang HL, Cook SE, et al. Galactosylated chitosan(GC)- graft-poly(vinylpyrrolidone)as hepatocyte-targeting DNA carrier: in ritro transfection[J]. Arch Pharm Res, 2004, 27(12): 1 284- 1 289.
  • 5Tsuji H, Osaka S, Kiwada H. Targeting of liposomes surface-modified with glycyrrhizin to the liver.Ⅰ. Preparation and biological disposition[J]. Chem Pharm Bull(Tokyo) , 1991,39(4): 1004- 1008.
  • 6Il'icheva TN,Proniaeva TR,Smetannikov AA,et al.Content of progesterone, glucocorticoid and glycyrrhizic acid receptors in normal and tumoral human breast tissue [J].Vopr Onkol, 1998, 44 (4) : 390 - 394.
  • 7Osaka S, Tsuji H, Kiwada H. Uptake of liposomes surface-modified with glycyrrhizin by primary cultured rat hepatocytes[ J ]. Biol Pharm Bull, 1994,17(7) : 940 - 943.
  • 8毛声俊,侯世祥,张良珂,金辉,毕岳琦,蒋彬.肝细胞靶向甘草酸表面修饰白蛋白纳米粒的制备工艺[J].药学学报,2003,38(10):787-790. 被引量:10
  • 9姚倩,侯世祥,何伟玲,冯骥良,王新春,费洪新,陈正华.表面氨基游离的白藜芦醇壳聚糖纳米粒制备方法研究[J].中国中药杂志,2006,31(3):205-208. 被引量:11
  • 10林爱华,刘奕明,平其能.壳聚糖纳米粒表面游离氨基与纳米粒特性研究[J].药学学报,2007,42(3):323-328. 被引量:24

二级参考文献31

  • 1张灿,丁娅,平其能.水溶性6-O-琥珀酰-N-半乳糖化壳聚糖衍生物的制备与表征[J].中国药科大学学报,2005,36(4):291-295. 被引量:21
  • 2姚倩,侯世祥,何伟玲,冯骥良,王新春,费洪新,陈正华.表面氨基游离的白藜芦醇壳聚糖纳米粒制备方法研究[J].中国中药杂志,2006,31(3):205-208. 被引量:11
  • 3范举正,李铜铃,庞其捷,管昌田,何勇,粟宽源.肝靶向抗病毒药NGA-ACV的制备及其趋肝性[J].药学学报,1996,31(8):585-590. 被引量:10
  • 4Yokoyama M, Okano T. Targetable drug carriem: present status and a future perspective[ J ]. Adv Drug Deliv Rev, 1996,21 (2): 77 - 80.
  • 5Verhoef JC, Junginger HE, Thanou M. Chitosan and its derivatives as intestinal absorption enhancers [ J ]. Adv Drug Deliv Rev, 2001,50(Suppl): S91 - S101.
  • 6Felt O, Buri P, Gurmy R. Chitosan: a unique polysaccharide for drug delivery[J]. Drug Dev Ind Pharm, 1998,24( 11 ) :979 - 993.
  • 7Vila A, Sanchez A, Tobyo M, et al. Design of biodegradable particles for protein delivery[ J ]. J Controlled Release, 2002,78 (1 - 3): 15 -20.
  • 8Wall DA, Wilson G, Hubbard AL. The galactosespecific recognition system of mammalian liver: the route of ligand internalization in rat hepatocytes[ J]. Cell, 1980,21( 1 ) :79 - 93.
  • 9Gao SY, Chen JN, Xu XR, et al. Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting[J]. Int J Pharm,2003,255( 1 ): 57 - 68.
  • 10Park YK, Park YH, Shin BA, et al. Galactosylated chitosan-graftdextran as hepatocyte-targeting DNA carrier [ J ]. J Controlled Release ,2000,69( 1 ) :97 - 108.

共引文献58

同被引文献115

引证文献11

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部